Joseph C. DosSantos
Plus aucun poste en cours
Profil
Joseph C.
DosSantos served as Chief Financial Officer at MYOS RENS Technology, Inc. from 2015 to 2016, at Luzsana Biotechnology, Inc. from 2021 to 2023, and at CareCloud, Inc. in 2023.
He received an undergraduate degree from Kean University in 1991 and an MBA from Seton Hall University.
Anciens postes connus de Joseph C. DosSantos
Sociétés | Poste | Fin |
---|---|---|
CARECLOUD, INC. | Directeur Financier/CFO | 10/05/2023 |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Part of Jiangsu Hengrui Pharmaceuticals Co., Ltd., Luzsana Biotechnology, Inc. is a biotechnology company that develops medicines. The company is based in Princeton, NJ. | Directeur Financier/CFO | 08/05/2023 |
MEDAVAIL HOLDINGS, INC. | Directeur Général | 17/12/2015 |
Formation de Joseph C. DosSantos
Kean University | Undergraduate Degree |
Seton Hall University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CARECLOUD, INC. | Technology Services |
Entreprise privées | 2 |
---|---|
MYOS RENS Technology, Inc.
MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ. | Health Technology |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Part of Jiangsu Hengrui Pharmaceuticals Co., Ltd., Luzsana Biotechnology, Inc. is a biotechnology company that develops medicines. The company is based in Princeton, NJ. | Health Technology |